Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12552856 | Anti-PCRV antibodies that bind PCRV, compositions comprising anti-PCRV antibodies, and methods of use thereof | 🖼🧊📄§ | 2026-02-17 | 2043-04-19 | 0 | 31 |
| 12551368 | Bioerodible ocular drug delivery insert and therapeutic method | 🖼🧊📄§ | 2026-02-17 | 2042-02-14 | 0 | 31 |
| 12551566 | Dual amylin and calcitonin receptor agonists and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2042-10-28 | 0 | 31 |
| 12552792 | Solid forms of an FGFR inhibitor and processes for preparing the same | 🖼🧊📄§ | 2026-02-17 | 2042-09-12 | 0 | 31 |
| 12552875 | Anti-human Cripto-1 antibody | 🖼🧊📄§ | 2026-02-17 | 2040-11-10 | 0 | 31 |
| 12551480 | Treatment using EYP001 | 🖼🧊📄§ | 2026-02-17 | 2040-07-17 | 0 | 31 |
| 12551494 | Pharmaceutical composition for preventing or treating dengue fever | 🖼🧊📄§ | 2026-02-17 | 2042-02-17 | 0 | 31 |
| 12551557 | Targeted chimeric antigen receptor modified T cells for treatment of IL13RALPHA2 positive malignancies | 🖼🧊📄§ | 2026-02-17 | 2041-03-12 | 0 | 31 |
| 12551464 | N-(3-amino-3-oxopropyl)-2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]benzamide and its use for treating HIV infection | 🖼🧊📄§ | 2026-02-17 | 2040-12-17 | 0 | 31 |
| 12551540 | Dosing and administration of recombinant L-asparaginase | 🖼🧊📄§ | 2026-02-17 | 2042-03-30 | 0 | 31 |
| 12552778 | Analogs for the treatment of disease | 🖼🧊📄§ | 2026-02-17 | 2042-08-05 | 0 | 31 |
| 12551502 | Testosterone enhancing compositions and methods | 🖼🧊📄§ | 2026-02-17 | 2045-03-28 | 0 | 31 |
| 12552869 | CSF-1R antibodies for the treatment of chronic graft versus host disease | 🖼🧊📄§ | 2026-02-17 | 2040-12-09 | 0 | 31 |
| 12551495 | Phytoecdysones and derivatives thereof for use in treating disordered respiratory function on viral infection | 🖼🧊📄§ | 2026-02-17 | 2041-03-24 | 0 | 31 |
| 12551468 | Pharmaceutical composition for oral administration, for treatment of liver cancer | 🖼🧊📄§ | 2026-02-17 | 2040-11-25 | 0 | 31 |
| 12552848 | Hydrochloride salts of C5a receptor agonist peptides | 🖼🧊📄§ | 2026-02-17 | 2038-06-12 | 0 | 31 |
| 12551477 | Oral antagonist compositions for nicotine burning relief | 🖼🧊📄§ | 2026-02-17 | 2040-09-22 | 0 | 31 |
| 12552760 | Compounds for increasing the nicotinamide adenine dinucleotide in a subject and methods of use thereof | 🖼🧊📄§ | 2026-02-17 | 2043-04-21 | 0 | 31 |
| 12552852 | Chimeric antigen receptor t lymphocyte for treating tumors, preparation method therefor, and use thereof | 🖼🧊📄§ | 2026-02-17 | 2041-09-08 | 0 | 31 |
| 12552846 | Modified BCL9 mimetic peptides | 🖼🧊📄§ | 2026-02-17 | 2040-07-06 | 0 | 31 |
| 12551523 | HIF-1 activator | 🖼🧊📄§ | 2026-02-17 | 2042-10-04 | 0 | 31 |
| 12551505 | Composition for bone regeneration comprising METTL7A overexpressing stem cells, method for preparing same, and cell therapy product comprising same | 🖼🧊📄§ | 2026-02-17 | 2041-06-18 | 0 | 31 |
| 12551498 | Treatment of P53-deficient cancers | 🖼🧊📄§ | 2026-02-17 | 2040-07-27 | 0 | 31 |
| 12552834 | Selective MENA binding peptides | 🖼🧊📄§ | 2026-02-17 | 2042-01-25 | 0 | 31 |
| 12552784 | 1H-pyrrolo[2,3-b]pyridine derivatives as BCL-2 inhibitors for the treatment of neoplastic and autoimmune diseases | 🖼🧊📄§ | 2026-02-17 | 2040-12-22 | 0 | 31 |
| RE050799 | JAK1 selective inhibitors and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2043-03-16 | 0 | 31 |
| 12552756 | Deuterated aminothiazole compounds as antiviral compounds | 🖼🧊📄§ | 2026-02-17 | 2041-10-28 | 0 | 31 |
| 12552840 | Identification of inhibitor peptides to bind with n-terminal spike (s) and nonstructural protein (NSP) sequences of SARS-COV2 b.1.617.2 Delta or Omicron variants alone and combination with drug(s) for targeted antiviral therapy | 🖼🧊📄§ | 2026-02-17 | 2042-05-04 | 0 | 31 |
| 12552825 | C10-alkylene substituted 13-membered macrolides and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2039-11-18 | 0 | 31 |
| 12552810 | Crystalline forms of CFTR modulators | 🖼🧊📄§ | 2026-02-17 | 2041-08-12 | 0 | 31 |
| 12551515 | Methods and compositions for treating cancer | 🖼🧊📄§ | 2026-02-17 | 2039-11-21 | 0 | 31 |
| 12551475 | Methods and compositions for treating RNA viral infections | 🖼🧊📄§ | 2026-02-17 | 2041-06-01 | 0 | 31 |
| 12551484 | Methods of treatment and/or prevention of major adverse cardiovascular events (MACE) with a combination of a BET bromodomain inhibitor and a sodium dependent glucose transport 2 inhibitor | 🖼🧊📄§ | 2026-02-17 | 2040-11-04 | 0 | 31 |
| 12551437 | Liposome compositions comprising weak acid drugs and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2045-01-07 | 0 | 31 |
| 12544362 | Methods of treating acute respiratory distress syndrome with activators of Tie-2 | 🖼🧊📄§ | 2026-02-10 | 2041-05-20 | 0 | 31 |
| 12545669 | Cycloalkyl and heterocycloalkyl benzisoxazole sulfonamide derivatives | 🖼🧊📄§ | 2026-02-10 | 2040-06-17 | 0 | 31 |
| 12544386 | Method and composition for treatment of skin diseases associated with accelerated corneodesmosomes degradation or weaker cell-cell adhesion | 🖼🧊📄§ | 2026-02-10 | 2040-05-13 | 0 | 31 |
| 12544444 | Administration of tailored feedstock to increase antibiotic susceptibility | 🖼🧊📄§ | 2026-02-10 | 2039-08-22 | 0 | 31 |
| 12544392 | Treatment of adenovirus infection or disease associated with adenovirus infection | 🖼🧊📄§ | 2026-02-10 | 2044-12-13 | 0 | 31 |
| 12544443 | Photodynamic therapy comprising two light exposures at different wavelengths | 🖼🧊📄§ | 2026-02-10 | 2043-03-22 | 0 | 31 |
| 12544441 | Compositions comprising CelTOS immunogens and antibodies and method of use thereof | 🖼🧊📄§ | 2026-02-10 | 2043-03-23 | 0 | 31 |
| 12544396 | Compositions and methods for treating metabolic disease | 🖼🧊📄§ | 2026-02-10 | 2040-06-01 | 0 | 31 |
| 12545687 | Uracil derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same | 🖼🧊📄§ | 2026-02-10 | 2043-04-07 | 0 | 31 |
| 12544372 | Methods of treating rheumatoid arthritis, chronic spontaneous urticaria, and systemic lupus erythematosis using an inhibitor of Bruton's tyrosine kinase | 🖼🧊📄§ | 2026-02-10 | 2041-07-21 | 0 | 31 |
| 12545739 | Compositions and methods for making and using bispecific antibodies | 🖼🧊📄§ | 2026-02-10 | 2038-11-13 | 0 | 31 |
| 12544403 | Methods to treat mitochondrial-associated dysfunctions or diseases | 🖼🧊📄§ | 2026-02-10 | 2040-01-10 | 0 | 31 |
| 12545689 | Macrocyclic LRRK2 kinase inhibitors | 🖼🧊📄§ | 2026-02-10 | 2041-05-05 | 0 | 31 |
| 12545730 | Optimized anti-CD3 arm in the generation of t-cell bispecific antibodies for immunotherapy | 🖼🧊📄§ | 2026-02-10 | 2040-12-15 | 0 | 31 |
| 12544345 | Compounds and combinations thereof for treating neurological and psychiatric conditions | 🖼🧊📄§ | 2026-02-10 | 2045-06-25 | 0 | 31 |
| 12544355 | Use of monascinol in preparation of fat-reducing product | 🖼🧊📄§ | 2026-02-10 | 2041-07-09 | 0 | 31 |